A detailed history of Exodus Point Capital Management, LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 117,984 shares of CYTK stock, worth $5.64 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
117,984
Previous 92,933 26.96%
Holding current value
$5.64 Million
Previous $5.04 Million 23.73%
% of portfolio
0.04%
Previous 0.03%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$51.22 - $60.16 $1.28 Million - $1.51 Million
25,051 Added 26.96%
117,984 $6.23 Million
Q2 2024

Aug 13, 2024

BUY
$47.86 - $75.05 $2.28 Million - $3.58 Million
47,669 Added 105.31%
92,933 $5.04 Million
Q1 2024

May 14, 2024

SELL
$63.75 - $108.06 $10.2 Million - $17.2 Million
-159,469 Reduced 77.89%
45,264 $3.17 Million
Q3 2023

Nov 09, 2023

SELL
$29.46 - $36.61 $240,364 - $298,700
-8,159 Reduced 3.83%
204,733 $6.03 Million
Q2 2023

Aug 10, 2023

SELL
$32.62 - $40.75 $1.88 Million - $2.35 Million
-57,557 Reduced 21.28%
212,892 $6.95 Million
Q1 2023

May 11, 2023

BUY
$33.36 - $45.71 $3.64 Million - $4.99 Million
109,116 Added 67.63%
270,449 $9.52 Million
Q4 2022

Feb 13, 2023

BUY
$35.77 - $51.11 $5.77 Million - $8.25 Million
161,333 New
161,333 $7.39 Million
Q3 2022

Nov 10, 2022

SELL
$38.54 - $54.52 $3.81 Million - $5.38 Million
-98,740 Closed
0 $0
Q2 2022

Aug 19, 2022

BUY
$33.93 - $48.92 $3.35 Million - $4.83 Million
98,740 New
98,740 $3.88 Million
Q1 2022

May 13, 2022

SELL
$29.74 - $46.0 $773,626 - $1.2 Million
-26,013 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$34.35 - $46.38 $1.74 Million - $2.35 Million
-50,572 Reduced 66.03%
26,013 $1.19 Million
Q3 2021

Nov 15, 2021

BUY
$18.54 - $35.74 $835,597 - $1.61 Million
45,070 Added 143.01%
76,585 $2.74 Million
Q2 2021

Aug 16, 2021

SELL
$19.79 - $26.99 $434,806 - $592,997
-21,971 Reduced 41.08%
31,515 $624,000
Q1 2021

May 17, 2021

BUY
$18.57 - $25.68 $993,235 - $1.37 Million
53,486 New
53,486 $1.24 Million
Q1 2020

May 15, 2020

SELL
$8.75 - $16.3 $169,610 - $315,959
-19,384 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$7.95 - $11.84 $154,102 - $229,506
19,384 New
19,384 $206,000

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.5B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.